Financial review A successful year: the value of the Groups holdings in portfolio companies increased to 285.9m Statement of comprehensive income For the year to 31 December 2013, the A summary analysis of the Groups financial performance is provided below: Group achieved a profit after tax of 72.6m, 2013 2012 m m compared to a profit of 40.7m in 2012.
Net portfolio gains 83.0 50.2 This result includes a 5.0m reduction in the fair Other income 2.4 2.3 value of the Groups contract with the University of Change in fair value Oxfords Department of Chemistry 2012: 6.0m of Oxford Equity reduction.
Excluding this non-cash fair value Rights asset 5.0 6.0 reduction, the Group recorded an adjusted profit Administrative of 77.6m compared to 46.7m in 2012, largely expenses Modern Biosciences 0.5 0.5 reflecting significantly higher net portfolio gains in Administrative the year.
expenses all other Greg Smith Chief Financial Officer businesses 7.7 6.2 Finance income 0.4 0.9 Profit and total comprehensive income for the year 72.6 40.7 Net portfolio gains consist primarily of realised and unrealised fair value gains and losses from the Groups equity and debt holdings in spin-out businesses as well as changes in the fair value of its limited and limited liability partnership interests.
A detailed analysis of fair value gains and losses is provided in the Portfolio review on pages 14 to 26.
com 27 23002-04 Proof 8a 01-04-14 Strategic Report Our Performance Financial review continued The Groups administrative expenses, The Group finished 2013 with cash and excluding those relating to MBS, deposits of 24.1m 2012: 47.9m and Testimonial: increased during the period to 7.7m a diversified portfolio of equity and debt Capital 2012: 6.2m, predominantly due to investments in 72 private and publicly higher staff costs, and included an listed technology companies IFRS 2 share-based payments charge 2012: 67.
On 14 February 2014 the IP Group has great totalling 0.9m 2012: 0.8m relating to Group announced its further equity links to the City.
They the Groups Long-Term Incentive Plan capital raise of 100m of cash before know the small cap investment awards.
This non-cash charge reflects expenses.
community and have put us in the fair value of services received from The value of the Groups holdings touch with various funds who are employees, measured by reference to the in portfolio companies increased to now investors.
As a shareholder fair value of the share-based payments at 285.9m at year end 2012: 181.8m themselves, they have been very the date of award, but has no net impact after net unrealised fair value gains of supportive and patient, following on the Groups total equity or net assets.
82.4m and net investment of 22.0m their money several times.
The IP In April 2013, the 2010 LTIP awards 2012: 38.0m net unrealised fair value Group team genuinely understands partially vested with 9,495,195 shares, gain: 9.6m net investment.
The Portfolio how a real trading business works representing 81% of the original award, review on pages 14 to 26 contains a which is markedly different from being issued to the relevant members detailed description of the Groups other small cap funds.
of the Companys staff as a result of the portfolio of equity and debt investments Groups strong three-year share price John McArthur, CEO including key developments and Tracsis plc performance and an increase in hard movements during the year.
Further detail is included in the Directors Remuneration Report on The Groups statement of financial pages 53 to 70.
The 2011 and 2012 LTIP position includes goodwill of 18.4m awards are subject to vesting conditions Other income for the year increased 2012: 18.4m and an equity rights until 2014 and 2015 and charges slightly to 2.4m 2012: 2.3m as an asset of 2.9m 2012: 7.9m.
The relating to these awards will continue increase in dividend income from Getech goodwill balances arose as a result of to be recognised in the statement of and Tracsis was largely offset by a lower the Groups historical acquisitions of comprehensive income until this time.
level of venture capital fund management Techtran Group university partnership The 2011 LTIP award will ordinarily vest fees.
This reduction occurred as IP Venture business, 16.3m: 2012: 16.3m and Top on or after 31 March 2014 and, based on Fund continued in its post investment Technology Ventures venture capital the results presented in this report, 100% period run-off.
However, this too was fund management business, 2.1m: 2012: of the 2011 awards are anticipated to vest offset by the Group raising a successor 2.1m.
The equity rights asset represents during 2014. fund, IP Venture Fund II, in May 2013.
The amounts paid to the University of Oxford Group continues to receive management in 2000 and 2001 giving the Group the As a result of the Groups decreased fees and has the potential to generate right to receive 50% of the universitys average cash balances during the year, performance fees from successful entitlement to equity in any spin-out the Groups interest receivable during the investment performance of both IP company and of any licensing income period fell to 0.4m 2012: 0.9m.
It is Venture Fund and the NETF, whose emanating from the University of Oxfords expected that the Groups future finance investment period is currently anticipated Department of Chemistry until 2015. income will continue to fluctuate broadly to continue until the end of 2014. in line with cash held on balance sheet As highlighted in 2012, the date of and future interest rate changes.
expiry November 2015 of the contract The Group continued to allocate limited underpinning the Oxford Equity Rights capital to the evaluation and development Statement of financial position Asset draws closer, and the value to the of certain early-stage therapeutic The Group ended the period with net Group of the corresponding asset under programmes, including through its assets attributable to shareholders of IFRS reduces.
The asset value will have subsidiary Modern Biosciences plc 337.0m, representing an increase of been written off by way of fair value MBS.
These development costs were 73.9m from the position at 1 January reduction or impairment through the expensed to the income statement as 2013 263.1m.
As described above, statement of comprehensive income by they were incurred.
In November 2012, the most significant contributor to the expiry date.
Based on the directors the Group announced that MBS had been the increase in net assets during the calculations, and as described more awarded a grant of up to 1.6m by the UK period was the performance of the fully in note 14 to the Groups financial Government-backed Biomedical Catalyst.
Groups portfolio of holdings in spinstatements, the fair value of the contract The award is providing support for MBSs out companies.
Hard net assets, i. e. at 31 December 2013 has reduced by lead anti-inflammatory programme, those excluding intangible assets and 5.0m 2012: 6.0m.
The Group intends to continue the Oxford Equity Rights asset, totalled developing a small number of early-stage 315.5m at 31 December 2013 2012: therapeutic assets.
IP Group plc Annual Report and Accounts for the year ended 31 December 2013 28 23002-04 Proof 8a 01-04-14 Strategic Report Our Performance Due to the nature of its activities, the It remains the Groups policy to place Total equity net assets m Group has limited current assets or cash which is surplus to near-term current liabilities other than its cash and working capital requirements on short- 336.6m 2012: 263.1m short-term deposit balances, which are term and overnight deposits with financial considered in more detail below.
institutions that meet the Groups 336.6 treasury policy criteria and in low-risk Cash, cash equivalents and treasury funds rated AA or above.
The 263.1 short-term deposits Cash Groups treasury policy is described in 221.6 The principal constituents of the 173.1 detail in note 2 to the Group financial 171.0 movement in Cash during the year are statements alongside details of the credit summarised as follows: ratings of the Groups cash and deposit 2013 2012 counterparties.
m m 2009 2010 2011 2012 2013 At 31 December 2013, the Group Net cash used in recognises 1.3m of loans 2012: nil operating activities Profit loss attributable to equity holders m from the limited partners of IPVFII, a excluding cash flows fund raised during the period which is from deposits 1.9 2.6 72.6m 2012: 40.7m consolidated into the Groups year-end Net cash used in figures.
These loans are only repayable investing activities 21.9 10.0 72.6 upon IPVFII generating sufficient returns Issued share capital to repay the limited partners.
Whilst the 40.7 Group continued to have no borrowings, Movement during it may in the future consider introducing a period 23.8 12.6 modest level of gearing into the business 1.8 6.1 5.5 if this is considered to be in the best At 31 December 2013, the Groups interests of the Group.
Cash totalled 24.1m, a decrease of 2009 2010 2011 2012 2013 23.8m from a total of 47.9m at During the period, the Group 31 December 2012 predominantly due incorporated a new subsidiary, IP Group to net investment in the Groups spin-out Cash, cash equivalents and deposits m Inc. in Delaware, USA in order to support companies.
the development of US-based intellectual 24.1m 2012: 47.9m property commercialisation opportunities.
The Groups net cash used in investing The Group holds a total of 0.1m activities increased during 2013, reflecting 60.5 2012: nil in US dollars.
both an increase in investments 2013: 47.9 27.5m: 2012: 26.3m and a decrease in Taxation realisations 2013: 5.5m: 2012: 16.7m.
Since the Groups activities are mainly 28.1 As described in more detail in the trading in nature, the directors continue 24.1 21.5 Portfolio review on pages 14 to 26, the to believe that the Group qualifies for Group allocated a total of 27.5m across the Substantial Shareholdings Exemption 44 portfolio companies during the period 2009 2010 2011 2012 2013 SSE on chargeable gains arising on 2012: 26.3m: 43 companies.
the disposal of qualifying holdings and, as such, the Group has continued not A further 0.2m was committed to IP to recognise a provision for deferred Venture Fund 2012: 0.4m, which in taxation in respect of uplifts in value turn invested 1.4m across six portfolio on those equity stakes which meet companies 2012: 3.0m: 15 companies the qualifying criteria.
The Groups and realised 1.8m from one partial unrecognised deferred tax assets and disposal.
Overall, net cash used in liabilities are set out in note 9 to the investing activities totalled 21.9m financial statements.
Primarily as a result of a 1.1m increase in trade and other payables, which was partially offset by higher administrative costs during the period, cash used in operating activities decreased to 1.9m 2012: 2.6m.
com 29 23002-04 Proof 8a 01-04-14 Strategic Report Our Performance
